Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lemaitre Vascular (LMAT) Long-Term Debt Repayments (2019 - 2021)

Lemaitre Vascular (LMAT) has disclosed Long-Term Debt Repayments for 3 consecutive years, with $78.0 million as the latest value for Q4 2021.

  • On a quarterly basis, Long-Term Debt Repayments rose 271.43% to $78.0 million in Q4 2021 year-over-year; TTM through Sep 2022 was $78.0 million, a 533.33% increase, with the full-year FY2021 number at $39.0 million, up 56.0% from a year prior.
  • Long-Term Debt Repayments was $78.0 million for Q4 2021 at Lemaitre Vascular, up from -$23.0 million in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $78.0 million in Q4 2021 to a low of -$23.0 million in Q3 2021.